-
Photovoltaic 24
-
Wind energy 6
-
Other renewable energy (nuclear, geothermal, etc.) 22
-
Grid/power transmission 23
-
Energy storage 31
-
Hydrogen energy 10
-
Lithium batteries 48
-
Electric vehicles 45
-
Low-carbon buildings and construction 7
-
Agriculture 11
-
Low-carbon consumer goods 6
-
New materials 22
-
Industrial manufacturing 7
-
Green transportation 22
-
CCUS 2
-
Digital technology for carbon accounting and consulting 22
-
Bio-Tech 2
-
Circular economy 31
All investors
114 institutional investors
Content Filter
-
Photovoltaic 24
-
Wind energy 6
-
Other renewable energy (nuclear, geothermal, etc.) 22
-
Grid/power transmission 23
-
Energy storage 31
-
Hydrogen energy 10
-
Lithium batteries 48
-
Electric vehicles 45
-
Low-carbon buildings and construction 7
-
Agriculture 11
-
Low-carbon consumer goods 6
-
New materials 22
-
Industrial manufacturing 7
-
Green transportation 22
-
CCUS 2
-
Digital technology for carbon accounting and consulting 22
-
Bio-Tech 2
-
Circular economy 31
-
GTJA Investment Group
- Investments: 134
- Funds: 87
- Shenzhen, Guangdong Province
-
Lithium batteries
-
Electric vehicles
-
Bio-Tech
Founded in Shenzhen in 2001, GTJA Investment Group focuses on investment in the medical health industry and is dominated by strategic equity investment, covering all stages of mergers and acquisitions, PE, VC, and angels. We have a medical investment team with leading scale and professionalism in China to build a ecoplatform for medical health industry. We are committed to becoming a medical health investment institution with global influence. GTJA's investment layout includes biopharmaceuticals, medical devices and medical services. With an asset management scale of over 20 billion RMB and 35 medical health industry funds, we have invested in more than 160 companies, including more than 90 medical health companies, and promoted the successful listing of 34 companies.
-
Haier Capital
- Investments: 139
- Funds: 19
- Shanghai
-
Lithium batteries
-
Grid/power transmission
-
Other renewable energy (nuclear, geothermal, etc.)
Haier Capital, founded in 2010, is the investment platform of Haier Financial Holding. Our business mainly involve venture capital, private equity investment, industrial mergers and acquisitions, and government guidance funds. Haier Capital focuses on the medical health field, including medical technology, medical services, medical equipments, and biomedicine. So far, we have managed more than 20 billion investment assets. We invest in smart technology, innovative consumption, andmedical health. The investment enterprises include Ijiami, Ubox, Dayun Motor, Dekun, Huatu Education, and Create LED.
-
Hankang Capital
- Investments: 75
- Funds: 13
- Shanghai
-
Photovoltaic
-
Grid/power transmission
-
Digital technology for carbon accounting and consulting
Hankang Capital (formerly "Shanghai Jianxin Capital") is a venture capital focusing on the biomedical industry. We pay attention to major diseases and major clinical needs, carry out in-depth research, support pioneering companies with first-class team and technology platform in advance, and provide professional insights, experience and resources in product pipeline, team building, application and registration, clinical trials, etc. to promote them to become leading enterprises in the industry as soon as possible. We have invested in Innocare Pharma Limited, Akeso, Chip Screen, Keymed Biosciences, AbbiskoTherapeutics and other industry leading companies. Hankang Capital has won the honors such as "TOP 100 Venture Capital Institutions", "TOP 20 Healthcare Investment Institutions", and "TOP 50 Venture Capital Institutions Recognized by LP in China" for many times.
-
Hongtai Aplus
- Investments: 319
- Funds: 35
- Beijing
-
Agriculture
Hongtai Aplus was founded in 2014 by Mr. Yu Minhong, founder of New Oriental and Mr. Sheng Xitai, the first chairman of Huatai United Securities. Its investment focuses on five major areas: information technology, advanced manufacturing, medicine and health care, new energy, new materials and new consumption. At present, the company is now managing funds of 30 billion yuan and has invested in 300 enterprises, which explains its extensive influence in China's investment and business circles. After years of development, Hongtai Aplus has made in-depth layout in related fields by virtue of its professional investment ability, successively invested in a number of unicorn/quasi-unicorn enterprises, and has been deeply trusted by investors. Up to now, Hongtai Aplus has more than ten funds under management, with mature investment layout in angel investment + VC, PE and parent fund.
-
IDG Capital
- Investments: 1456
- Funds: 140
- Beijing
-
Energy storage
-
Photovoltaic
-
Hydrogen energy
-
Lithium batteries
-
Electric vehicles
-
Grid/power transmission
-
New materials
-
Industrial manufacturing
-
Green transportation
IDG Capital, founded in 1992, is a leading investment institution in the world, focusing on supporting outstanding enterprises in different growth cycles to achieve rapid development through venture capital, private equity and industrial development. IGD Capital has invested in more than 1,400 enterprises including 360, Baidu, Ctrip.com, Afu Essential Oil, Andon Medical, Archermind, Baofeng, Bilibili, Cobos, Bosideng, Birentech, China UMS, Fftai, Heytea, Iqiyi, Ijovo and Three Squirrels. IDG Capital has one of the most complete and experienced professional teams in the industry. The team members have diversified industry backgrounds and global investment perspectives and resources, and their education and working backgrounds cover many industries such as technology, market, finance, law, management consulting and investment banking.